Navigation Links
BioImagene Raises $26 M in Expansion Capital
Date:8/19/2008

BioImagene, the leading provider of affordable digital pathology solutions for cancer diagnosis and preclinical research, today announced the closing of a $26 million series D financing round led by Burrill & Company. Ascension Health Ventures, National Healthcare Services and existing investors Artiman Ventures and ICCP Ventures also joined the round with strong support.

CUPERTINO, Calif. (Business Wire EON) August 19, 2008 -- Mr. Yatin Mundkur, Artiman Ventures Partner and BioImagene board member noted "This follow-on investment reaffirms our commitment to the BioImagene team and their innovative products, and reinforces our belief in the enormous growth potential of digital pathology. We are very happy to guide the company through their next phase of future growth."

BioImagene CEO Mohan Uttarwar commented, "This latest infusion of capital from leading investors is a strong vote of confidence in our team, products and strategy. Our goal is to become the dominant player in this space by 2010. We are within range of our target and this funding will help us scale operations to support the rapidly increasing demand for affordable, integrated digital pathology systems. "

Digital pathology is the process of converting entire glass microscope slides into high-resolution, whole-slide digital images that can be viewed, managed and analyzed with a computer instead of a microscope—along with digital pathology management systems that help interpret the information generated from the digitized glass slide.

Digital pathology applications utilizing digital slides are gaining momentum as pathologists can access slide specimens and related data from any location in the world, fostering more efficient laboratory workflow, physician communication, education and research at a reasonable cost.

Investor Information

For more information on Artiman Ventures, please visit www.artimanventures.com

For more information on Ascension Health Ventures, please visit www.ascensionhealthventures.org

For more information on Burrill & Company, please visit www.burrillandco.com

For more information on National Healthcare Services (NHS), please visit www.nationalhealthcareservices.com

For more information on ICCP Ventures, please visit www.iccpventurepartners.com

About BioImagene

BioImagene is a leading provider of total digital pathology solutions for applications including clinical diagnostics and drug discovery. BioImagene products are FDA -cleared for specific clinical applications, and are intended for research use for other applications. www.bioimagene.com.

Read the full story at http://www.prweb.com/releases/bioimagene/ventures/prweb1227644.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Low Vitamin D Raises Womens Hip Fracture Risk
2. NJHA Raises Questions Regarding Horizons Proposal to Convert to For-Profit Health Insurer
3. Stater Bros. Raises $200,000 for the Leukemia & Lymphoma Society
4. Summer Games Swap Raises Questions About Image, Oral Health
5. Dunkin Donuts Event Raises $800,000 for Cancer Research in One Day
6. The Ensign Group, Inc. Reports Second Quarter 2008 Earnings of $.32 per Diluted Share and Raises 2008 Guidance
7. GI Bleeding After Stroke Raises Death Risk
8. Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital
9. Genoptix Reports Strong Financial Results for the Second Quarter and Raises Guidance for Full-Year 2008
10. Secondhand Smoke Raises Stroke Risk for Spouses
11. CVS/pharmacy Raises Record-breaking $4.4 Million for ALS Research Through Annual ALS Fundraising Campaign
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 BioImagene Raises $26 M in Expansion Capital 
(Date:10/12/2017)... ... 2017 , ... HMP , a leader in healthcare events and education, today ... Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & ... award competition recognizes editorial and design excellence across a range of sectors. This year’s ...
(Date:10/12/2017)... Chapel, FL (PRWEB) , ... October 12, 2017 , ... ... is holding a treadmill relay – Miles by Moonlight to raise money for the ... donating $300 or more. , Teams will work together to keep their treadmills ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health ... interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), an ... education, today announce a new strategic alliance. , As CPEN’s strategic partner, ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... latest in wound care advancements to physician colleagues, skilled nursing facility medical directors ... "Navigating the Treacherous Waters of Wound Care." , "At many of these conferences ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Pepper Flow promotional review platform at the Promotional Review Committee Compliance and ... help marketers streamline the medical, legal, and regulatory review (MLR) process – ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, Inc. ... Day Software and Consulting, LLC , and named its ... Software, based in Tennessee , will ... Day expands EnvoyHealth,s service offerings for health care partners ... "In an interoperable world, ...
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host ... webcast on Friday, November 3, 2017, beginning at 7:00 ... approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... performance and guidance for 2018, Hill-Rom executives will also ... performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: